The European Commission has given a conditional marketing authorisation to the Covid-19 vaccine developed by Janssen Pharmaceutica NV following a positive scientific review by the European Medicines Agency. The decision, announced on 11 March, comes just under two weeks after the US gave the same vaccine an emergency use authorisation.
